Nvidia Corp (NVDA) - Nvidia Corp has doubled in price from $72 to $144 since February, with a split-adjusted target of $160 by 2027 [1] Dogecoin (DOGE-USD) and Zero-Day Options - Dogecoin surged from $0 10 to $0 64 in 2021, highlighting the potential of high-volatility bets [2] - Zero-day options, expiring within the same day, are among the fastest-growing segments in financial markets, with traders achieving profits ranging from 16% to 1,306% in short periods [2][3] Sabre Corp (SABR) - Sabre Corp operates the Global Distribution System (GDS), a critical network for airline and hotel reservations, with no viable alternative currently available [6][7] - The company is highly leveraged, with $1 of equity for every $4 of debt, making it sensitive to changes in enterprise value [5] - Sabre's shares dropped from the $20-$30 range to single digits during the Covid-19 pandemic, currently trading at $3 60 [9] - Air travel has rebounded above pre-Covid levels, with Sabre's booking revenues nearly tripling since 2020, and the company is expected to generate $86 million in net income in 2025, up from a $57 million loss in 2024 [10][11] Stratasys Ltd (SSYS) - Stratasys is a leader in 3D printing, having acquired key players like RPS and XAAR to strengthen its technological lead [12] - The company's F3300 printer is one of the fastest in its price class, with net profits expected to surge tenfold to $26 million in 2025 [13] - Potential 20% tariffs could further boost Stratasys's profitability by forcing domestic manufacturers to buy locally produced parts [14] Evolv Technologies Holdings Inc (EVLV) - Evolv's shares fell 50% due to an internal accounting investigation, but the company remains a top moonshot bet [15] - The company specializes in AI-powered scanning gates for detecting hidden weapons, with products used in stadiums, schools, and event spaces [16] - Potential new gun-friendly laws and testing with the TSA could significantly increase demand for Evolv's products [17] UiPath Inc (PATH) - UiPath's shares have fallen 83% since its 2021 IPO due to slowing growth and management turnover [18] - Analysts forecast a return to accelerating growth in 2025, driven by increasing demand for AI-driven business automation [19] - UiPath is recognized as a leading visionary in business automation by Gartner, with growth expected to accelerate as AI becomes more advanced [20] Pfizer Inc (PFE) and Trump's Policies - Pfizer earns 25% of its revenues from Covid-19 vaccines and therapies, making it highly exposed to vaccine-related policies [23] - Trump's potential policies, such as repealing Medicare negotiation provisions and reducing FTC oversight, could benefit healthcare stocks [24] - Traders are using at-the-market 2026 Pfizer straddles to capitalize on potential volatility, with payoffs if PFE shares move outside the $19 50-$30 50 range by January 2026 [25] Zero-Day Options Market - The zero-day options market sees around $1 trillion exchanged daily, offering significant potential for dramatic gains [27] - Jonathan Rose's strategy for profiting from zero-day options has yielded returns of up to 463% in 30 days or less [29] - A free masterclass on zero-day options will be held on November 26, focusing on strategies for rapid gains [28][30]

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) and certain of the Company’s current and former senior executives. If you invested in Evolv, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc. Investors have until December 31, 2024 to ask the Court to be appointed to lead the ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Evolv To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Evolv between August 19, 2022 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 22, 2024 (GLOBE NEWS ...

PHILADELPHIA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) on behalf of purchasers of Evolv securities between August 19, 2022 through October 30, 2024, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired EVOLV securities during the Class Period may, no later than DECEMBER 31, 2024, seek to be appointed as a lea ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Evolv To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Evolv between August 19, 2022 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Nov. 21, 2024 /PRNewswire/ -- ...

NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV).Shareholders who purchased shares of EVLV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/evolv-technologies-holdings-inc-loss-submission-form-2/?id=112801&from= ...

SAN DIEGO, Nov. 20, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) securities between August 19, 2022 and October 30, 2024. Evolv is a security technology company that utilizes AI-based screening designed to help create safer experiences.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allega ...

Core Viewpoint - A lawsuit has been filed against Evolv Technologies Holdings, Inc. and certain current and former executives, alleging material misstatements in financial statements related to revenue recognition from Q2 2022 to Q2 2024 [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Massachusetts, captioned Buchan v. Evolv Technologies Holdings, Inc., No. 1:24-cv-12768 [2]. - Investors have until December 31, 2024, to request to lead the case [2]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. Group 2: Financial Misstatements - Evolv's financial statements from Q2 2022 to Q2 2024 are alleged to contain material misstatements regarding revenue recognition and other metrics [3]. - On October 25, 2024, Evolv announced that its financial statements should not be relied upon due to these misstatements, which included undisclosed extracontractual terms affecting sales [4]. - The company self-reported these issues to the SEC and delayed its Q3 2024 quarterly report [4]. Group 3: Stock Price Impact - Following the announcement of the financial misstatements, Evolv's stock price dropped approximately 40%, from $4.10 on October 24, 2024, to $2.47 on October 25, 2024 [4]. - After the termination of CEO Peter George on October 31, 2024, the stock price fell about 8%, from $2.34 on October 30, 2024, to $2.15 on October 31, 2024 [5]. Group 4: Legal Representation - Bleichmar Fonti & Auld LLP is representing plaintiffs in this case, operating on a contingency fee basis, meaning no upfront costs for shareholders [6]. - The firm has a strong track record, having recovered over $900 million from Tesla's Board of Directors and $420 million from Teva Pharmaceutical Industries [8].

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Evolv Technologies Holdings, Inc. ("Evolv Technologies Holdings, Inc." or the "Company") (NASDAQ: EVLV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Evolv Technologies Holdings, Inc. investors who were adversely affected by alleged securities fraud between August 19, 2022 and October 30, 2024. Follow the link below to get more information and be contacted by a member ...

NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ: EVLV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Evolv and certain of it ...